Enlivex Therapeutics Ltd. (ENLV) Insider Trading Activity

NASDAQ$1.36-0.1 (-6.85%)
Market Cap
$24.57M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
531 of 849
Rank in Industry
307 of 491

ENLV Insider Trading Activity

ENLV Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
–
Sells
$0
0
–

Related Transactions

About Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd., established in 2005 and based in Nes Ziona, Israel, operates as a clinical-stage biotechnology firm dedicated to macrophage reprogramming immunotherapy. The company is currently advancing Allocetra, its flagship cell-based therapeutic. This treatment is undergoing Phase II clinical evaluation for its effectiveness in addressing organ dysfunction and failure that arises from sepsis. Additionally, Allocetra is being investigated in preclinical studies for its potential application in solid tumor therapy.

Insider Activity of Enlivex Therapeutics Ltd.

Over the last 12 months, insiders at Enlivex Therapeutics Ltd. have bought $0 and sold $0 worth of Enlivex Therapeutics Ltd. stock.

On average, over the past 5 years, insiders at Enlivex Therapeutics Ltd. have bought $0 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

List of Insider Buy and Sell Transactions, Enlivex Therapeutics Ltd.

2015-10-09SaleMurray Michael Anthonyformer SVP - Operations
56,390
0.6424%
$2.78
$156,764
-54.86%
Total: 1

ENLV Institutional Investors: Active Positions

Increased Positions15+50%814,478+116.67%
Decreased Positions11-36.67%189,985-27.21%
New Positions5New121,917New
Sold Out Positions9Sold Out144,636Sold Out
Total Postitions34+13.33%1M+89.46%

ENLV Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Morgan Stanley$131.000.07%173,625-45,524-20.77%2025-09-30
Renaissance Technologies Llc$119.000.07%157,292-11,100-6.59%2025-09-30
Citadel Advisors Llc$52.000.03%68,936+68,936New2025-09-30
Susquehanna International Group, Llp$41.000.02%54,850+54,850New2025-09-30
Xtx Topco Ltd$32.000.02%42,668+42,668New2025-09-30
Two Sigma Securities, Llc$26.000.01%34,242+34,242New2025-09-30
Sigma Investment Counselors Inc$21.000.01%28,00000%2025-09-30
Jane Street Group, Llc$16.000.01%21,529-39,523-64.74%2025-09-30
Hrt Financial Lp$14.000.01%18,792+18,792New2025-09-30
Prosperity Consulting Group, Llc$13.000.01%17,647+17,647New2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.